Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 120
Filter
Add more filters










Publication year range
1.
Article in English | MEDLINE | ID: mdl-12052050

ABSTRACT

Although it is now generally accepted that long-chain N-acylethanolamines and their precursors, N-acylethanolamine phospholipids, exist as trace constituents in virtually all vertebrate cells and tissues, their possible biological functions are just emerging. While anandamide (N-arachidonoylethanolamine) has received much attention due to its ability to bind to and activate cannabinoid receptors, the saturated and monounsaturated N-acylethanolamines, which usually represent the vast majority, are cannabinoid receptor-inactive but appear to interact with endocannabinoids and to have other signaling functions as well. Also, primary fatty acid amides, including the amide of oleic acid, which acts as a sleep-inducing agent, do not interact with cannabinoid receptors but are catabolically related to endocannabinoids. Here we review published information on the occurrence, metabolism, and possible signaling functions of the cannabinoid receptor-inactive N-acylethanolamines and primary fatty acid amides.


Subject(s)
Amides/metabolism , Ethanolamines/metabolism , Fatty Acids/metabolism , Receptors, Drug/metabolism , Animals , Cannabinoid Receptor Modulators , Cannabinoids/metabolism , Eicosanoids/metabolism , Receptors, Cannabinoid
2.
Biochem J ; 360(Pt 1): 67-75, 2001 Nov 15.
Article in English | MEDLINE | ID: mdl-11695993

ABSTRACT

Anandamide and other polyunsaturated N-acylethanolamines (NAEs) exert biological activity by binding to cannabinoid receptors. These receptors are linked to G(i/o) proteins and their activation leads to extracellular-signal-regulated protein kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase (MAP kinase) activation, inhibition of cAMP-dependent signalling and complex changes in the expression of various genes. Saturated and monounsaturated NAEs cannot bind to cannabinoid receptors and may thus mediate cell signalling through other targets. Here we report that both saturated/monounsaturated NAEs and anandamide (20:4(n-6) NAE) stimulate cannabinoid-receptor-independent ERK phosphorylation and activator protein-1 (AP-1)-dependent transcriptional activity in mouse epidermal JB6 cells. Using a clone of JB6 P(+) cells with an AP-1 collagen-luciferase reporter construct, we found that 16:0, 18:1(n-9), 18:1(n-7), 18:2(n-6) and 20:4(n-6) NAEs stimulated AP-1-dependent transcriptional activity up to 2-fold, with maximal stimulation at approx. 10-15 microM. Higher NAE concentrations had toxic effects mediated by alterations in mitochondrial energy metabolism. The AP-1 stimulation appeared to be mediated by ERK but not JNK or p38 signalling pathways, because all NAEs stimulated ERK1/ERK2 phosphorylation without having any effect on JNK or p38 kinases. Also, overexpression of dominant negative ERK1/ERK2 kinases completely abolished NAE-induced AP-1 activation. In contrast with 18:1(n-9) NAE and anandamide, the cannabinoid receptor agonist WIN 55,212-2 did not stimulate AP-1 activity and inhibited ERK phosphorylation. The NAE-mediated effects were not attenuated by pertussis toxin and appeared to be NAE-specific, as a close structural analogue, oleyl alcohol, failed to induce ERK phosphorylation. The data support our hypothesis that the major saturated and monounsaturated NAEs are signalling molecules acting through intracellular targets without participation of cannabinoid receptors.


Subject(s)
Ethanolamines/chemistry , Ethanolamines/metabolism , Receptors, Drug/metabolism , Signal Transduction , Analgesics/pharmacology , Animals , Benzoxazines , Cell Line , Cells, Cultured , Dose-Response Relationship, Drug , Epidermis/metabolism , MAP Kinase Signaling System , Mice , Microscopy, Phase-Contrast , Mitochondria/metabolism , Mitogen-Activated Protein Kinase 8 , Mitogen-Activated Protein Kinases/metabolism , Morpholines/pharmacology , Naphthalenes/pharmacology , Phosphorylation , Radioligand Assay , Receptors, Cannabinoid , Time Factors , Transcription Factor AP-1/metabolism , Transcription, Genetic , p38 Mitogen-Activated Protein Kinases
3.
J Neurochem ; 78(6): 1415-27, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11579150

ABSTRACT

Endogenous cannabinoid receptor ligands (endocannabinoids) may rescue neurons from glutamate excitotoxicity. As these substances also accumulate in cultured immature neurons following neuronal damage, elevated endocannabinoid concentrations may be interpreted as a putative neuroprotective response. However, it is not known how glutamatergic insults affect in vivo endocannabinoid homeostasis, i.e. N-arachidonoylethanolamine (anandamide) and 2-arachidonoylglycerol (2-AG), as well as other constituents of their lipid families, N-acylethanolamines (NAEs) and 2-monoacylglycerols (2-MAGs), respectively. Here we employed three in vivo neonatal rat models characterized by widespread neurodegeneration as a consequence of altered glutamatergic neurotransmission and assessed changes in endocannabinoid homeostasis. A 46-fold increase of cortical NAE concentrations (anandamide, 13-fold) was noted 24 h after intracerebral NMDA injection, while less severe insults triggered by mild concussive head trauma or NMDA receptor blockade produced a less pronounced NAE accumulation. By contrast, levels of 2-AG and other 2-MAGs were virtually unaffected by the insults employed, rendering it likely that key enzymes in biosynthetic pathways of the two different endocannabinoid structures are not equally associated to intracellular events that cause neuronal damage in vivo. Analysis of cannabinoid CB(1) receptor mRNA expression and binding capacity revealed that cortical subfields exhibited an up-regulation of these parameters following mild concussive head trauma and exposure to NMDA receptor blockade. This may suggest that mild to moderate brain injury may trigger elevated endocannabinoid activity via concomitant increase of anandamide levels, but not 2-AG, and CB(1) receptor density.


Subject(s)
Arachidonic Acids/metabolism , Nerve Degeneration/metabolism , Animals , Brain Concussion/metabolism , Cannabinoid Receptor Modulators , Cerebral Cortex/metabolism , Corpus Striatum/drug effects , Craniocerebral Trauma/metabolism , Dizocilpine Maleate/pharmacology , Endocannabinoids , Ethanolamines/metabolism , Excitatory Amino Acid Agonists/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Glycerides/metabolism , Male , N-Methylaspartate/pharmacology , Polyunsaturated Alkamides , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Cannabinoid , Receptors, Drug/genetics , Receptors, Drug/metabolism
4.
FASEB J ; 15(12): 2171-8, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11641243

ABSTRACT

The endocannabinoid signaling system is believed to play a down-regulatory role in the control of cell functions. However, little is known about the factors activating endocannabinoid synthesis and which of two known endocannabinoids, 2-arachidonoylglycerol (2-AG) or N-arachidonoylethanolamine (20:4n-6 NAE, anandamide), is of physiological importance. We approached these questions by studying a possible link between cell activation with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor, PAF) and the generation of 2-AG and anandamide in human platelets and mouse P388D1 macrophages. Human platelets responded to stimulation with the production of various 1- and 2-monoacylglycerols, including 2-AG, whereas stimulation of P388D1 macrophages induced the rapid and selective generation of 2-AG, which was immediately released into the medium. The effect of PAF was receptor mediated, as PAF receptor antagonist BN52021 blocked the effect. The treatment did not change the content of anandamide in either macrophages or platelet-rich plasma. The inhibitors of PI- and PC-specific phospholipases C (U73122 and D609) as well as PI3-kinase inhibitor (wortmannin) attenuated PAF-induced 2-AG production in macrophages. These data suggest a direct role for the endocannabinoid system in controlling immune cell activation status and indicate that 2-AG rather than anandamide is the endocannabinoid rapidly produced in response to proinflammatory stimulation of immune cells.


Subject(s)
Blood Platelets/immunology , Glycerides/biosynthesis , Macrophages/immunology , Platelet Membrane Glycoproteins/metabolism , Receptors, Cell Surface , Receptors, G-Protein-Coupled , Animals , Arachidonic Acids/biosynthesis , Blood Platelets/drug effects , Cannabinoid Receptor Modulators , Cell Line , Centrifugation , Endocannabinoids , Humans , Kinetics , Macrophages/drug effects , Mice , Phosphatidylinositol Diacylglycerol-Lyase , Platelet Activating Factor/pharmacology , Polyunsaturated Alkamides , Type C Phospholipases/metabolism
5.
J Biol Chem ; 276(15): 11775-82, 2001 Apr 13.
Article in English | MEDLINE | ID: mdl-11278294

ABSTRACT

The sphingomyelin-ceramide pathway is an evolutionarily conserved ubiquitous signal transduction system that regulates many cell functions including apoptosis. Sphingomyelin (SM) is hydrolyzed to ceramide by different sphingomyelinases. Ceramide serves as a second messenger in mediating cellular effects of cytokines and stress. In this study, we find that acid sphingomyelinase (SMase) activity was induced by UVA in normal JY lymphoblasts but was not detectable in MS1418 lymphoblasts from Niemann-Pick type D patients who have an inherited deficiency of acid SMase. We also provide evidence that UVA can induce apoptosis by activating acid SMase in normal JY cells. In contrast, UVA-induced apoptosis was inhibited in MS1418 cells. Exogenous SMase and its product, ceramide (10-40 micrometer), induced apoptosis in JY and MS1418 cells, but the substrate of SMase, SM (20-80 micrometer), induced apoptosis only in JY cells. These results suggest that UVA-induced apoptosis by SM is dependent on acid SMase activity. We also provide evidence that induction of apoptosis by UVA may occur through activation of JNKs via the acid SMase pathway.


Subject(s)
Apoptosis/radiation effects , Sphingomyelin Phosphodiesterase/metabolism , Ultraviolet Rays , Animals , Cell Line, Transformed , Enzyme Activation , Enzyme Inhibitors/pharmacology , Flavonoids/pharmacology , Humans , Imidazoles/pharmacology , Mice , Mice, Knockout , Mitogen-Activated Protein Kinases/metabolism , Phosphorylation , Pyridines/pharmacology , Sphingomyelin Phosphodiesterase/genetics
6.
J Biol Chem ; 276(23): 20523-8, 2001 Jun 08.
Article in English | MEDLINE | ID: mdl-11279117

ABSTRACT

The mechanisms by which synchronized embryonic development to the blastocyst stage, preparation of the uterus for the receptive state, and reciprocal embryo-uterine interactions for implantation are coordinated are still unclear. We show in this study that preimplantation embryo development became asynchronous in mice that are deficient in brain-type (CB1) and/or spleen-type (CB2) cannabinoid receptor genes. Furthermore, whereas the levels of uterine anandamide (endocannabinoid) and blastocyst CB1 are coordinately down-regulated with the onset of uterine receptivity and blastocyst activation prior to implantation, these levels remained high in the nonreceptive uterus and in dormant blastocysts during delayed implantation and in pregnant, leukemia inhibitory factor (LIF)-deficient mice with implantation failure. These results suggest that a tight regulation of endocannabinoid signaling is important for synchronizing embryo development with uterine receptivity for implantation. Indeed this is consistent with our finding that while an experimentally induced, sustained level of an exogenously administered, natural cannabinoid inhibited implantation in wild-type mice, it failed to do so in CB1(-/-)/CB2(-/-) double mutant mice. The present study is clinically important because of the widely debated medicinal use of cannabinoids and their reported adverse effects on pregnancy.


Subject(s)
Cannabinoids/pharmacology , Receptors, Drug/physiology , Signal Transduction , Uterus/physiology , Amino Acid Sequence , Animals , Cannabinoid Receptor Modulators , Cannabinoids/metabolism , Female , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Mutant Strains , Models, Molecular , Molecular Sequence Data , Receptors, Cannabinoid , Receptors, Drug/genetics , Receptors, Drug/metabolism , Sequence Homology, Amino Acid , Uterus/drug effects , Uterus/metabolism
8.
Chem Phys Lipids ; 108(1-2): 71-87, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11106783

ABSTRACT

Long-chain N-acylethanolamines (NAEs) and their precursors, N-acylethanolamine phospholipids, are ubiquitous trace constituents of animal and human cells, tissues and body fluids. Their cellular levels appear to be tightly regulated and they accumulate as the result of injury. Saturated and monounsaturated congeners which represent the vast majority of cellular NAEs can have cytoprotective effects while polyunsaturated NAEs, especially 20:4n-6 NAE (anandamide), elicit physiological effects by binding to and activating cannabinoid receptors. It is the purpose of this article to review published data on the pathways and mechanisms of NAE biosynthesis in mammals and to evaluate this information for its physiological significance. The generation and turnover of NAE via N-acyl PE through the transacylation-phosphodiesterase pathway may represent a novel cannabinoid receptor-independent signalling system, analogous to and possibly related to ceramide-mediated cell signalling.


Subject(s)
Arachidonic Acids/biosynthesis , Ethanolamine/metabolism , Animals , Endocannabinoids , Humans , Polyunsaturated Alkamides
9.
Biochem J ; 346 Pt 2: 369-74, 2000 Mar 01.
Article in English | MEDLINE | ID: mdl-10677355

ABSTRACT

It has long been known that N-acylethanolamine phospholipids [N-acylphosphatidylethanolamine (N-acyl PE)] and N-acylethanolamines (NAEs) accumulate in mammalian tissues undergoing degenerative membrane changes associated with necrosis. Here we studied the effects of stress factors (UVB irradiation and serum deprivation) on the endogenous levels of N-acyl PE and NAE in mouse epidermal JB6 P(+) cells. We found that 16:0, 18:0, 18:1,n-9 and 18:1,n-7 are the predominant amide-linked fatty acids in both N-acyl PE and NAE in these cells. UVB irradiation and serum deprivation resulted in significantly increased levels of N-acyl PE and NAE, especially 18:1, n-9 N-acyl PE and NAE. UVB challenge increased the cellular content of anandamide (20:4,n-6 NAE), but this increase was the lowest of all NAEs measured. Serum deprivation resulted in a decreased cellular anandamide level, as well as a decrease in 20:4,n-6 N-acyl PE. Interestingly, the replacement of serum-free medium with medium containing 5% (v/v) fetal calf serum after 36 h of serum deprivation restored N-acyl PE and NAE levels almost completely within 4-8 h. These data suggest the involvement of N-acyl PE and NAE in cellular responses to stress.


Subject(s)
Epidermis/metabolism , Ethanolamines/metabolism , Animals , Cell Line , Culture Media, Serum-Free , Epidermis/pathology , Epidermis/radiation effects , Mice , Ultraviolet Rays
10.
Chem Phys Lipids ; 104(2): 185-91, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10669310

ABSTRACT

Mammalian cells produce both N-arachidonoylethanolamine (20:4n-6 NAE, anandamide) and 2-arachidonoylglycerol (2-AG), lipid signaling molecules that activate cannabinoid receptors. Because both agonists occur in the presence of receptor-inactive congeners, we have developed a sensitive method for the simultaneous assay of N-acylethanolamines (NAEs) and 2-monoacylglycerols (2-MAG). These lipid classes are isolated from total lipids by solid phase extraction and converted to tert-butyldimethylsilyl (tBDMS) derivatives in the presence of deuterated analogs. The tBDMS derivatives are analyzed by gas chromatography/mass spectrometry using selected ion monitoring programs specific for NAE and 2-MAG. Individual NAEs and 2-MAGs can be quantified in the nanogram and subnanogram range. The NAE and 2-MAG compositions of rat organs and cultured JB6 cells are reported.


Subject(s)
Arachidonic Acids/analysis , Cannabinoids/analysis , Glycerides/analysis , Neurotransmitter Agents/analysis , Animals , Arachidonic Acids/isolation & purification , Cannabinoid Receptor Modulators , Chromatography, High Pressure Liquid/methods , Endocannabinoids , Gas Chromatography-Mass Spectrometry/methods , Glycerides/isolation & purification , Indicators and Reagents , Kidney/chemistry , Liver/chemistry , Male , Myocardium/chemistry , Polyunsaturated Alkamides , Rats , Rats, Zucker , Sensitivity and Specificity , Spleen/chemistry , Testis/chemistry
11.
FEBS Lett ; 459(1): 123-7, 1999 Oct 01.
Article in English | MEDLINE | ID: mdl-10508930

ABSTRACT

Polyunsaturated N-acylethanolamines (NAEs), including anandamide (20:4n-6 NAE), elicit a variety of biological effects through cannabinoid receptors, whereas saturated and monounsaturated NAEs are inactive. Arachidonic acid mobilization induced by treatment of intact mouse peritoneal macrophages with Ca2+ ionophore A23187 had no effect on the production of NAE or its precursor N-acylphosphatidylethanolamine (N-acyl PE). Addition of exogenous ethanolamine resulted in enhanced NAE synthesis by its N-acylation with endogenous fatty acids, but this pathway was not selective for arachidonic acid. Incorporation of (18)O from H2 (18)O-containing media into the amide carbonyls of both NAE and N-acyl PE demonstrated a rapid, constitutive turnover of both lipids.


Subject(s)
Arachidonic Acids/metabolism , Ethanolamines/metabolism , Macrophages, Peritoneal/metabolism , Acylation , Animals , Arachidonic Acids/biosynthesis , Calcimycin/pharmacology , Carbon Radioisotopes , Endocannabinoids , Ethanolamine/pharmacology , Ionophores/pharmacology , Macrophages, Peritoneal/drug effects , Male , Mice , Mice, Inbred ICR , Polyunsaturated Alkamides
12.
Biochim Biophys Acta ; 1393(1): 211-21, 1998 Jul 31.
Article in English | MEDLINE | ID: mdl-9714808

ABSTRACT

The inflammatory compounds beta-glucan, a particulate agonist, and tannin, a soluble agonist, are present in cotton dust and, when inhaled, cause massive arachidonic acid release from alveolar macrophages. Earlier work had shown that these agonists exhibit different effects on arachidonate liberation and release, and that only tannin inhibits the uptake and incorporation of exogenous arachidonic acid, suggesting inhibition of reacylation. Here we have used the time-dependent incorporation of 18O from H218O-containing media into glycerophospholipid acyl groups as an indicator of acyl turnover in resting and agonist-treated rabbit alveolar macrophages. Highest turnover rates were seen in phosphatidylinositol ( approximately 30% per hour) and in choline phospholipids (10-20% per hour). Both beta-glucan and tannin stimulated acyl turnover, especially arachidonic acid turnover, in these and other lipid classes by a factor of 2 or more. We conclude that neither agonist promotes arachidonic acid accumulation in and release from alveolar macrophages by inhibiting reacylation.


Subject(s)
Arachidonic Acids/analysis , Glucans/pharmacology , Hydrolyzable Tannins/pharmacology , Macrophages, Alveolar/drug effects , Phosphatidic Acids/metabolism , Acylation/drug effects , Animals , Fatty Acids/analysis , Macrophages, Alveolar/metabolism , Oxygen Isotopes , Phosphatidic Acids/chemistry , Rabbits
13.
Biol Reprod ; 58(6): 1490-5, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9623610

ABSTRACT

We examined the relative importance of G (Gi) protein-coupled brain-type (CB1-R) and spleen-type (CB2-R) cannabinoid receptors in preimplantation embryo development using agonists and antagonists specific to CB1-R and CB2-R. The results establish that endogenous cannabinoid ligands, anandamide and sn-2 arachidonoylglycerol, arrest embryo development in vitro, and this effect is reversed by CB1-R antagonists SR141716A or AM 251, but not by SR144528, a CB2-R antagonist. A CB2-R selective agonist AM 663 failed to affect embryo development. These results suggest that cannabinoid effects on embryo development are mediated by CB1-R. We also observed that delta9-tetrahydrocannabinol ([-]THC) infused in the presence of cytochrome P450 inhibitors interfered with blastocyst implantation. This adverse effect was reversed by coinfusion of SR141716A. The less active stereoisomer (+)THC plus the inhibitors failed to affect implantation. Analysis of tissue levels demonstrated that uterine accumulation of (-)THC occurred when it was infused in the presence of the P450 inhibitors. These results demonstrate that the uterus and perhaps the embryo have the cytochrome P450 enzymes to metabolize (-)THC and neutralize its adverse effects on implantation. Collectively, the present study demonstrates that cannabinoid effects on embryo development and implantation are mediated by embryonic and/or uterine CB1-R, but not CB2-R.


Subject(s)
Brain/metabolism , Cannabinoids/pharmacology , Embryo Implantation/drug effects , Embryonic Development , Embryonic and Fetal Development , Receptors, Drug/physiology , Animals , Arachidonic Acids/pharmacology , Cannabinoids/antagonists & inhibitors , Cytochrome P-450 Enzyme Inhibitors , Dronabinol/pharmacology , Embryo, Mammalian/drug effects , Endocannabinoids , Enzyme Inhibitors/pharmacology , Female , Glycerides/pharmacology , Male , Mice , Piperidines/pharmacology , Polyunsaturated Alkamides , Pregnancy , Pyrazoles/pharmacology , Receptors, Cannabinoid , Rimonabant
14.
Chem Phys Lipids ; 92(1): 27-35, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9631536

ABSTRACT

We have investigated the biosynthesis of long-chain N-acylethanolamines (NAEs) from endogenous substrates in rat testes membranes with special emphasis on anandamide (20:4n-6 NAE), a cannabinoid receptor agonist. Incubation of various membrane preparations with 5 mM Ca2+ produced both N-acyl phosphatidylethanolamine (N-acyl PE) and NAE with primarily (approximately 85%) N-palmitoyl groups (16:0 NAE) and less than 2% 20:4n-6 NAE. In contrast, incubation of these membranes with 5 mM EGTA and 10 mM ethanolamine had little effect on N-acyl PE composition but yielded NAEs whose major constituent (32-37%) was anandamide. Incubations with [1,1,2,2,-2H4]ethanolamine in media containing 40% H2(18)O showed that the Ca(2+)-independent NAE synthesis occurred by direct condensation of ethanolamine with free fatty acids present in the membrane preparation. This biosynthetic activity occurred at ethanolamine concentrations as low as 50 microM and exhibited substrate selectivity for arachidonate which increased with increasing ethanolamine concentrations. The results of inhibitor experiments suggest that the Ca(2+)-independent NAE synthesis was catalyzed by the NAE amidohydrolase acting in reverse. This condensation reaction could be important in agonist-induced anandamide synthesis for cell signalling through cannabinoid receptors.


Subject(s)
Arachidonic Acids/biosynthesis , Testis/metabolism , Amidohydrolases/metabolism , Animals , Arachidonic Acids/pharmacology , Calcium/metabolism , Cell Membrane/metabolism , Endocannabinoids , Ethanolamines/chemistry , Fatty Acids/chemistry , Male , Organophosphonates/pharmacology , Phosphatidylethanolamines/chemistry , Polyunsaturated Alkamides , Rats , Rats, Sprague-Dawley , Receptors, Cannabinoid , Receptors, Drug/agonists
15.
Lipids ; 32(11): 1181-7, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9397404

ABSTRACT

Freshly isolated rat hepatocytes were incubated for 20 min with [U-14C]glycerol in the presence or absence of unlabeled linoleic (18:2n-6), arachidonic (20:4n-6), or docosahexaenoic (22:6n-3) acid, added as albumin complex in 10% ethanol. Most of the radioactivity (approximately 95%) recovered in hepatocyte lipids was present in phosphatidylcholine (PC), phosphatidylethanolamine (PE), and triacylglycerol (TAG). The presence of exogenous fatty acids resulted in (i) higher incorporation of [U-14C]glycerol, (ii) higher percentage of label in TAG, and (iii) enhanced formation of PC and PE molecular species bearing the exogenous fatty acid at both the sn-1 and sn-2 positions of glycerol. In each case, these molecular species contained 60 to 70% of the label in that lipid class. Further incubation of the cells for 40 and 80 min in the absence of labeled substrate and exogenous fatty acids resulted in a redistribution of label among PC and PE molecular species due to deacylation-reacylation at the sn-1 position of glycerol.


Subject(s)
Fatty Acids, Unsaturated/metabolism , Liver/metabolism , Phospholipids/metabolism , Animals , Arachidonic Acid/metabolism , Caproates/metabolism , Chromatography, High Pressure Liquid , Chromatography, Thin Layer , Diglycerides/metabolism , Glycerol/metabolism , Linoleic Acid/metabolism , Male , Phosphatidylcholines/metabolism , Phosphatidylethanolamines/metabolism , Rats , Rats, Sprague-Dawley , Triglycerides/metabolism
16.
Lipids ; 32(9): 917-23, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9307931

ABSTRACT

Lipid peroxidation was induced in freshly isolated rat hepatocytes by incubation in the presence of Fe3+, resulting in accumulation of thiobarbituric acid reactive substances. Analysis of lipid classes revealed that the levels and fatty acid compositions of the two major phospholipids, phosphatidylcholine (PC) and phosphatidylethanolamine (PE), remained unchanged but the levels of triacylglycerols (TAG) were significantly reduced, and some of their polyunsaturated fatty acids were selectively lost as the result of oxidant treatment. Acyl turnover in PC and PE as determined by 18O incorporation from H2 (18)O-containing media remained largely unchanged during oxidant treatment, while some increased turnover of the saturated fatty acids in TAG was observed. We hypothesize that constitutive recycling of membrane phospholipids rather than selective in situ repair eliminates peroxidized species of PC and PE. TAG could serve as an expendable fatty acid reserve, providing a limited but very dynamic pool of polyunsaturated fatty acids for the resynthesis of phospholipids.


Subject(s)
Glycerophosphates/metabolism , Lipid Metabolism , Liver/metabolism , Oxidative Stress , Animals , Cells, Cultured , Fatty Acids/metabolism , Fatty Acids, Unsaturated/metabolism , Ferric Compounds/metabolism , Kinetics , Lipid Peroxidation , Lipid Peroxides/metabolism , Male , Membrane Lipids/metabolism , Oxygen Isotopes , Phosphatidylcholines/metabolism , Phosphatidylethanolamines/metabolism , Rats , Rats, Sprague-Dawley , Thiobarbituric Acid Reactive Substances/metabolism , Triglycerides/metabolism
17.
J Clin Invest ; 100(6): 1538-46, 1997 Sep 15.
Article in English | MEDLINE | ID: mdl-9294122

ABSTRACT

The endogenous cannabinoid receptor agonist anandamide is present in central and peripheral tissues. As the kidney contains both the amidase that degrades anandamide and transcripts for anandamide receptors, we characterized the molecular components of the anandamide signaling system and the vascular effects of exogenous anandamide in the kidney. We show that anandamide is present in kidney homogenates, cultured renal endothelial cells (EC), and mesangial cells; these cells also contain anandamide amidase. Reverse-transcriptase PCR shows that EC contain transcripts for cannabinoid type 1 (CB1) receptors, while mesangial cells have mRNA for both CB1 and CB2 receptors. EC exhibit specific, high-affinity binding of anandamide (Kd = 27.4 nM). Anandamide (1 microM) vasodilates juxtamedullary afferent arterioles perfused in vitro; the vasodilation can be blocked by nitric oxide (NO) synthase inhibition with L-NAME (0.1 mM) or CB1 receptor antagonism with SR 141716A (1 microM), but not by indomethacin (10 microM). Anandamide (10 nM) stimulates CB1-receptor-mediated NO release from perfused renal arterial segments; a similar effect was seen in EC. Finally, anandamide (1 microM) produces a NO-mediated inhibition of KCl-stimulated [3H]norepinephrine release from sympathetic nerves on isolated renal arterial segments. Hence, an anandamide signaling system is present in the kidney, where it exerts significant vasorelaxant and neuromodulatory effects.


Subject(s)
Arachidonic Acids/metabolism , Calcium Channel Blockers/metabolism , Kidney/blood supply , Renal Circulation/drug effects , Amidohydrolases/metabolism , Animals , Arachidonic Acids/pharmacology , Blotting, Southern , Calcium Channel Blockers/pharmacology , Cannabinoids/antagonists & inhibitors , Cells, Cultured , Dose-Response Relationship, Drug , Endocannabinoids , Ethanolamines/analysis , Indomethacin/pharmacology , Kidney/drug effects , Kidney/metabolism , Male , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/metabolism , Norepinephrine/metabolism , Phosphatidylethanolamines/analysis , Piperidines/pharmacology , Polyunsaturated Alkamides , Pyrazoles/pharmacology , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Rimonabant , Sympathetic Nervous System/drug effects , Vasodilation/drug effects
18.
Chem Phys Lipids ; 87(2): 103-10, 1997 Jul 14.
Article in English | MEDLINE | ID: mdl-9275307

ABSTRACT

N-acyl phosphatidylethanolamine (N-acyl PE) and free N-acylethanolamine (NAE) in mouse peritoneal macrophages were identified and quantified by gas chromatography-mass spectrometry (GC-MS) of tertbutyldimethylsilyl derivatives in the presence of internal standards synthesized from [1,1,2,2-2H4]ethanolamine. N-acyl PE was present at a level of 123-187 pmol/mumol lipid P (521-768 pmol/10(8) cells), with arachidonic acid making up about 3-4% of the N-acyl moieties. NAE, on the other hand, was present at a level of only 17-30 pmol/mumol lipid P (70-121 pmol/10(8) cells), with N-arachidonoylethanolamine (anandamide) making up less than 1% of total NAE. Use of deuterium labeled internal standards and optimization of GC-MS conditions makes it possible to detect as little as 0.1 ng of saturated and 1 ng (3 pmol) of polyunsaturated NAEs in a lipid extract. The present method can be used to determine agonist-induced changes in the levels and compositions of N-acyl PE and NAE.


Subject(s)
Arachidonic Acids/analysis , Ethanolamines/analysis , Macrophages, Peritoneal/chemistry , Acyltransferases/metabolism , Animals , Deuterium , Endocannabinoids , Ethanolamines/isolation & purification , Fatty Acids/chemistry , Gas Chromatography-Mass Spectrometry , Mice , Organosilicon Compounds/chemical synthesis , Phosphatidylethanolamines/analysis , Phosphatidylethanolamines/isolation & purification , Polyunsaturated Alkamides
19.
Proc Natl Acad Sci U S A ; 94(8): 4188-92, 1997 Apr 15.
Article in English | MEDLINE | ID: mdl-9108127

ABSTRACT

Anandamide (N-arachidonoylethanolamine) is an endogenous ligand for both the brain-type (CB1-R) and spleen-type (CB2-R) cannabinoid receptors. This investigation demonstrates that the periimplantation mouse uterus contains the highest levels of anandamide (142-1345 pmol/micromol lipid P; 1-7 microg/g wet weight) yet discovered in a mammalian tissue. The levels fluctuate with the state of pregnancy; down-regulation of anandamide levels is associated with uterine receptivity, while up-regulation is correlated with uterine refractoriness to embryo implantation. Anandamide levels are highest during the nonreceptive phase in the pseudopregnant uterus and in the interimplantation sites, and lowest at the site of embryo implantation. The lower levels of uterine anandamide at the implantation sites may be a mechanism by which implanting embryos protect themselves from the detrimental effects of this endogenous ligand. We also observed a reduced rate of zona-hatching of blastocysts in vitro in the presence of anandamide, and inhibition of implantation by systemic administration of a synthetic cannabinoid agonist CP 55,940. These adverse effects were reversed by SR141716A, a specific CB1-R antagonist. Taken together, the results suggest that an aberrant synthesis of anandamide and/or expression of the cannabinoid receptors in the uterus/embryo may account for early pregnancy failure or female infertility.


Subject(s)
Arachidonic Acids/metabolism , Pregnancy, Animal/metabolism , Uterus/metabolism , Animals , Arachidonic Acids/analysis , Biomarkers , Endocannabinoids , Female , Mice , Polyunsaturated Alkamides , Pregnancy
20.
J Biol Chem ; 272(7): 4187-94, 1997 Feb 14.
Article in English | MEDLINE | ID: mdl-9020132

ABSTRACT

Phorbol esters, which activate isoforms of protein kinase C, are general activators of the transcription factor activated protein 1 (AP-1). The pathway involved in this signal transduction is not very clear. Currently, little is known about whether phosphatidylinositol-3 (PI-3) kinase plays any role in phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced signal transduction. We demonstrate here that TPA not only has markedly synergistic effects on insulin-induced PI-3 kinase activity, but it also can induce PI-3 kinase activity and the PI-3 phosphates by itself. We also found that insulin, a PI-3 kinase activator, enhanced TPA-induced AP-1 trans-activation and transformation in JB6 promotion-sensitive cells. Furthermore, wortmannin and LY294002, two PI-3 kinase inhibitors, markedly decreased AP-1 activity induced by insulin, TPA, or TPA and insulin and inhibited JB6 promotion-sensitive cell transformation induced by TPA or TPA and insulin. Most importantly, constitutive overexpression of the dominant negative PI-3 kinase P85 mutants completely blocked insulin- or TPA-induced AP-1 trans-activation and TPA-induced cell transformation. All evidence from present studies suggests that PI-3 kinase acts as a mediator in TPA-induced AP-1 activation and transformation in JB6 cells.


Subject(s)
Cell Transformation, Neoplastic , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Transcription Factor AP-1/metabolism , Androstadienes/pharmacology , Animals , Cell Line , Chromones/pharmacology , Drug Interactions , Enzyme Activation , Enzyme Inhibitors/pharmacology , Epidermal Cells , Epidermis/drug effects , Epidermis/enzymology , Insulin/pharmacology , Mice , Morpholines/pharmacology , Phosphatidylinositol 3-Kinases , Phosphotransferases (Alcohol Group Acceptor)/antagonists & inhibitors , Transcription Factor AP-1/antagonists & inhibitors , Wortmannin
SELECTION OF CITATIONS
SEARCH DETAIL
...